These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32469090)

  • 21. Homocysteine and cardiovascular disease in diabetes mellitus.
    Audelin MC; Genest J
    Atherosclerosis; 2001 Dec; 159(2):497-511. PubMed ID: 11730832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study.
    Miranda-Machado P; Salcedo-Mejía F; Wilches JP; Fernandez-Mercado J; De la Hoz-Restrepo F; Alvis-Guzmán N
    BMC Cardiovasc Disord; 2019 Jan; 19(1):8. PubMed ID: 30621603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
    Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
    Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a Risk Profile for New-Onset Diabetes After Acute Pancreatitis.
    Firkins SA; Hart PA; Papachristou GI; Lara LF; Cruz-Monserrate Z; Hinton A; Conwell DL; Bradley DP; Krishna SG
    Pancreas; 2021 May-Jun 01; 50(5):696-703. PubMed ID: 34016890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects.
    Kim SS; Cho HJ; Kim HJ; Kang DR; Berry JR; Kim JH; Yang MJ; Lim SG; Kim S; Cheong JY; Cho SW
    Dig Liver Dis; 2018 Apr; 50(4):370-377. PubMed ID: 29398414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes.
    Nelson AJ; Peterson ED; Pagidipati NJ
    Prog Cardiovasc Dis; 2019; 62(4):306-314. PubMed ID: 31301314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.
    Mottillo S; Filion KB; Genest J; Joseph L; Pilote L; Poirier P; Rinfret S; Schiffrin EL; Eisenberg MJ
    J Am Coll Cardiol; 2010 Sep; 56(14):1113-32. PubMed ID: 20863953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012).
    Liu F; Du GL; Song N; Ma YT; Li XM; Gao XM; Yang YN
    Lipids Health Dis; 2020 Apr; 19(1):58. PubMed ID: 32238146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.
    Alexander N; Matsushita K; Sang Y; Ballew S; Mahmoodi BK; Astor BC; Coresh J
    Am J Nephrol; 2015; 41(4-5):409-17. PubMed ID: 26139323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome and chronic kidney disease.
    Belarbia A; Nouira S; Sahtout W; Guedri Y; Achour A
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):931-40. PubMed ID: 26354564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in metabolic parameters and adverse kidney and cardiovascular events during glomerulonephritis and renal vasculitis treatment in patients with and without diabetes mellitus.
    Lim CC; Choo JCJ; Tan HZ; Mok IYJ; Chin YM; Chan CM; Woo KT
    Kidney Res Clin Pract; 2021 Jun; 40(2):250-262. PubMed ID: 34024087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and peripheral artery disease: Two related conditions.
    Oriol Torón PÁ; Badía Farré T; Romaguera Lliso A; Roda Diestro J
    Endocrinol Nutr; 2016; 63(6):258-64. PubMed ID: 27165186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Metabolic Syndrome Components in High-Risk Cardiovascular Disease Development in Older Adults.
    Gustavo de Sousa Barbalho Y; Morato Stival M; Ramos de Lima L; Cristina Rodrigues da Silva I; de Oliveira Silva A; Vieira Gomes da Costa M; Cristina Morais Santa Barbara Rehem T; Schwerz Funghetto S
    Clin Interv Aging; 2020; 15():1691-1700. PubMed ID: 33061322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].
    Reindel J; Zander E; Heinke P; Kohnert KD; Allwardt C; Kerner W
    Herz; 2004 Aug; 29(5):463-9. PubMed ID: 15340731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.
    Bao X; Borné Y; Johnson L; Muhammad IF; Persson M; Niu K; Engström G
    Cardiovasc Diabetol; 2018 Jun; 17(1):87. PubMed ID: 29895294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between arm-to-leg and limbs-to-trunk body composition ratio and cardiovascular disease risk factors.
    Jung S; Park J; Seo YG
    Sci Rep; 2021 Aug; 11(1):17414. PubMed ID: 34465815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
    Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.